A nationwide recall involves one lot of propranolol hydrochloride extended-release 60 mg capsules, a medication used to treat high blood pressure, because of possible metal contamination. Breckenridge Pharmaceutical announced the voluntary recall Nov. 16.
Consumers should check for these product details.
| Product detail | Recalled medication |
|---|---|
| Medication | Propranolol Hydrochloride Extended-Release Capsules, USP |
| Strength | 60 mg |
| Company | Breckenridge Pharmaceutical |
| Package size | 100-count bottle |
| Lot number | PK25110035 |
| Expiration date | May 2029 |
| National Drug Code | 51991-817-01 |
The affected lot was distributed to wholesalers and pharmacies nationwide between Oct. 26 and Nov. 4. Potential metal contamination could cause cuts to soft tissue in the mouth, esophagus, stomach or intestines. Breckenridge said it was unaware of adverse events related to the recall when it issued the announcement.
Consumers with medication from the affected lot should immediately stop taking those capsules and contact their physician or health care provider for medical advice and replacement instructions, according to the company. Unused capsules should be returned to the pharmacy where they were obtained.
If the lot number is missing from a prescription bottle, a pharmacist can help determine whether the medication is affected. Questions about the recall can also be directed to Qualanex, Breckenridge’s recall service provider, at 855-736-0807, Monday through Friday, 9 a.m.–5 p.m. Eastern.




